Laboratory Blood-Based Testing for Non-Lyme Disease Tick-Borne Infections at a National Reference Laboratory

Author:

Lee-Lewandrowski Elizabeth12,Chen Zhen3,Branda John12,Baron Jason12,Kaufman Harvey W3

Affiliation:

1. Department of Pathology, Division of Clinical Laboratories and Molecular Medicine, Massachusetts General Hospital, Boston

2. Harvard Medical School, Boston, MA

3. Quest Diagnostics, Secaucus, NJ

Abstract

AbstractObjectivesWe evaluated trends in non-Lyme disease tick-borne disease (NLTBI) testing at a national reference laboratory.MethodsTesting data performed at Quest Diagnostics during 2010 to 2016 were analyzed nationally and at the state level.ResultsTesting and positivity for most NLTBIs increased dramatically from 2010 through 2016 based on testing from a large reference laboratory. The number of positive cases, though not as stringent as criteria for public health reporting, generally exceeds that reported by the Centers for Disease Control and Prevention. The frequency of NLTBI in the US is seasonal but testing activity and positive test results are observed throughout all months of the year. Positive results for NLTBI testing mostly originated from a limited number of states, indicating the geographic concentration and distribution of NLTBIs reported in this study.ConclusionsThis report provides an important complementary source of data to best understand trends in and spread of NLTBI.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Reference18 articles.

1. Commonwealth of Massachusetts. Lyme disease. http://www.mass.gov/eohhs/gov/departments/dph/programs/id/epidemiology/ticks/public-health-cdc-tickborne-lyme-faq.html#2. Accessed December 8, 2017.

2. Vital signs: trends in reported vectorborne disease cases-United States and territories, 2004-2016;Rosenberg;MMWR Morb Mortal Wkly Rep.,2018

3. Laboratory testing for tick-borne infections in a large northeastern academic medical center: an 11-year experience;Rudolf;Am J Clin Pathol.,2018

4. Lyme disease testing by large commercial laboratories in the United States;Hinckley;Clin Infect Dis.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3